Atea Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Atea Pharmaceuticals | 8-K: Atea Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BERGER FRANKLIN M
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Adams Jerome M.
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Polsky Bruce
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lucidi Bruno
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Murphy Polly A.
Atea Pharmaceuticals | 8-K: Current report
Atea Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Adams Jerome M.
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Polsky Bruce
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director BERGER FRANKLIN M
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lucidi Bruno
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Murphy Polly A.
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Duncan Barbara Gayle
Atea Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sommadossi Jean-Pierre
Atea Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Atea Pharmaceuticals | DEFA14A: Others
Atea Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
No Data